» Articles » PMID: 36839800

Parasitological, Molecular, and Histopathological Investigation of the Potential Activity of Propolis and Wheat Germ Oil Against Acute Toxoplasmosis in Mice

Abstract

Toxoplasmosis is one of the most common parasitic zoonoses that affects all vertebrates. The drugs most commonly used against toxoplasmosis have many side effects, making the development of new antiparasitic drugs a big challenge. The present study evaluated the therapeutic effectiveness of novel herbal treatments, including propolis and wheat germ oil (WGO), against acute toxoplasmosis. A total of 50 albino mice were divided into five groups: group 1 (G1) (non-infected and non-treated); group 2 (G2) (infected without treatment); group 3 (G3) (treated with propolis); group 4 (G4) (treated with WGO); group 5 (G5) (treated with a combination of propolis and WGO). The effects of the herbal substances on different organs, mainly liver, spleen, and lungs, were investigated using parasitological, molecular, and histopathological examinations. The results of parasitological examination demonstrated statistically significant ( < 0.05) differences in the parasitic load between treated groups (G3, G4, and G5) compared to the control positive group (G2). These differences were represented by a significant reduction in the parasite load in stained tissue smears from the liver obtained from the animals treated with propolis (G3) compared to the parasite load in the positive control group. Similarly, animals (G4) treated with WGO exhibited a significant reduction in the parasite load versus the positive control group, while the lowest parasite load was found in G5, treated with propolis and WGO. Quantification of the parasite burden through molecular methods (PCR) revealed similar findings represented by reduction in the parasite burden in all treated groups with WGO and propolis as compared to the control group. Importantly, these previous parasitological and molecular findings were accompanied by a marked improvement in the histopathological picture of the liver, spleen, and lungs. In conclusion, propolis and WGO showed a good combination of therapeutic efficacy against acute toxoplasmosis.

Citing Articles

Discovery of potent anti-toxoplasmosis drugs from secondary metabolites in Citrus limon (lemon) leaves, supported in-silico study.

Mohammed M, Mohammed H, El Wafa S, Ahmed D, Heikal E, Elgohary I Sci Rep. 2025; 15(1):624.

PMID: 39753625 PMC: 11698829. DOI: 10.1038/s41598-024-82787-9.


Effectiveness of Miltefosine Nanoemulsion Concerning the Treatment of Acute and Chronic Toxoplasmosis: In Vivo Study.

Valizadeh G, Mahboubian M, Maghsoud A, Mirzaei F, Haghi S, Parvar F Iran J Parasitol. 2024; 19(3):314-324.

PMID: 39318821 PMC: 11417982. DOI: 10.18502/ijpa.v19i3.16389.


Ameliorative effects of propolis and wheat germ oil on acute toxoplasmosis in experimentally infected mice are associated with reduction in parasite burden and restoration of histopathological changes in the brain, uterus, and kidney.

Elmahallawy E, Ali F, Raya-Alvarez E, Fehaid A, Abd El-Razik K, El Fadaly H Front Vet Sci. 2024; 11:1357947.

PMID: 38496314 PMC: 10940321. DOI: 10.3389/fvets.2024.1357947.


Potent In Vitro and In Vivo Effects of Methanolic Extract against Infection.

Alanazi A, Majeed Q, Alnomasy S, Almohammed H Trop Med Infect Dis. 2023; 8(7).

PMID: 37505651 PMC: 10384536. DOI: 10.3390/tropicalmed8070355.

References
1.
Mohamed Shaapan R, Toaleb N, Abdel-Rahman E . Significance of a common 65 kDa antigen in the experimental fasciolosis and toxoplasmosis. J Parasit Dis. 2015; 39(3):550-6. PMC: 4554586. DOI: 10.1007/s12639-013-0394-2. View

2.
Cohen S, Denkers E . The gut mucosal immune response to Toxoplasma gondii. Parasite Immunol. 2014; 37(3):108-17. DOI: 10.1111/pim.12164. View

3.
Siheri W, Ebiloma G, Igoli J, Gray A, Biddau M, Akrachalanont P . Isolation of a Novel Flavanonol and an Alkylresorcinol with Highly Potent Anti-Trypanosomal Activity from Libyan propolis. Molecules. 2019; 24(6). PMC: 6471328. DOI: 10.3390/molecules24061041. View

4.
Fuentes-Castro B, Reyes-Garcia J, Valenzuela-Vargas M, Martinez-Gomez F . Histopathology of murine toxoplasmosis under treatment with dialyzable leukocyte extract. Mem Inst Oswaldo Cruz. 2017; 112(11):741-747. PMC: 5661896. DOI: 10.1590/0074-02760170045. View

5.
Dunay I, Gajurel K, Dhakal R, Liesenfeld O, Montoya J . Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice. Clin Microbiol Rev. 2018; 31(4). PMC: 6148195. DOI: 10.1128/CMR.00057-17. View